Skip to content

NAMMD

National Agency for Medicines and Medical Devices

  • HOME
  • ABOUT THE INSTITUTION
    • About us
    • Legislation (organisation and operation of the institution)
    • Management
      • Management
      • Management staff
      • Administration Council
      • Scientific Council
    • Organisation
      • Organisational and operational rules and regulations
      • Departments
      • Organisational chart
      • Careers
    • List of employees assigned in working groups
    • Programmes and strategies
    • Quality policy
    • Reports and studies
  • INFORMATION FOR THE PUBLIC
    • Requests for information. Legislation
      • Name of the person responsible for compliance with provisions of Law 544/2001
      • Application form provided in Law 544/2001
      • Challenge of decisions and associated forms for administrative complaint (refusal and failure to comply with legal deadlines)
      • Public documents and NAMMD managed/generated documents
      • Implementation reports on Law 544/2001
    • Informative bulletin
    • Budget – funding source
      • Budget and funding source (as of year 2016)
      • Status of payments (budget execution)
      • Status of wage payment and other rights
    • Balance sheet
    • Public procurement
      • Annual schedule of public procurement
      • Summary of public procurement
      • Public procurement contracts
    • Declarations of interest
    • Financial disclosure statements
  • CONTACT
    • Contact data
    • Bank accounts and CUI (Unique Registration Number)
    • Media relations
    • Business hours
    • Contact persons
    • Audience form
    • On-line enquiries/requests
    • Useful links
  • RO

Pharmaceutical inspection

> Romanian manufacturers – Medicinal products and active substances

> NAMMD certified manufacturers in third countries

> Import authorised sites

> Wholesale authorised sites

> Medicinal product control laboratories

> Withdrawn/Recalled medicinal product batches

> NAMMD certified/Qualified Persons

> NAMMD penalised sites

> EudraGMP

Agency

> Programmes and strategies
> Activity reports
> Informative Bulletin
> Press releases
> FAQ
> Counterfeiting
> Facebook

Medicines for human use

> Important notifications – Medicines for human use
> Legislation – Medicines for human use
> Forms and tariffs – Medicines for human use
> Medicinal product authorisation
> Parallel import authorisation
> Health technologies assessment
> Clinical trials
> Last resort treatments
> Pharmacovigilance
> Report an adverse reaction
> Direct healthcare professionals communications
> Submit a medicinal product quality complaint
> Inform on medicinal product shortage
> Medicinal products under additional monitoring
> Pharmaceutical inspection
> Advertising
> Readability
> Standard terms
> Intra-Community deliveries notifications
> Drug discontinuity notifications
> Sponsorships – Medicinal products for human use
> Index of medicinal products for human use

Medical Devices

> Important notifications – Medical Devices
> Legislation – Medical Devices
> Forms and fees – Medical Devices
> European regulations on medical devices
> CE marking
> Definitions and classification of medical devices
> Registration of medical devices into the national database
> Grant of customs notice
> Grant of donation notice
> Grant of out-of-scope notice
> Vigilance
> Market surveillance
> In-use surveillance
> Clinical investigation
> Notified bodies
> Operation notice
> Record of EU/EEA service providers into the database
> Grant of notice for use
> Grant of periodic check bulletin
> Report an incident
> Sponsorships – Medical Devices

Search the site

Subscribe to our newsletter

Copyright © 2017 NAMMD
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.I agreeRead more